Key result
Transcatheter mitral valve replacement (TMVR) was performed with successful outcomes in 5 patients with degenerated mitral valve bioprostheses.
Why the study?
Mitral regurgitation is the leading cause of heart valve disease worldwide, with its incidence gradually surpassing aortic valve stenosis in an aging population.
Does transcatheter mitral valve replacement (TMVR) improve outcomes in patients with degenerated mitral valve bioprosthesis?
Case Report (n=5)
Does transcatheter mitral valve replacement (TMVR) improve outcomes in patients with degenerated mitral valve bioprosthesis?
TMVR may be a feasible and successful treatment option for patients with degenerated mitral valve bioprostheses and rheumatic heart disease.
Mitral regurgitation (MR) is the leading cause of heart valve disease worldwide. In aging population, the incidence of mitral regurgitation (MR) has gradually surpassed that of aortic valve stenosis. We present a report of 5 cases,with history of rheumatic heart disease and old malfunction bioprosthetic valve, presenting with dyspnea, poor ejection fraction.Investigations revealed severe mitral stenosis and regurgitation. TMVR (trans catheter mitral valve replacement) was done with successful outcome.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2023) conducted a case report in Degenerated mitral valve bioprosthesis with severe mitral stenosis and regurgitation (n=5). Transcatheter mitral valve replacement (TMVR) was evaluated on Successful outcome. Transcatheter mitral valve replacement (TMVR) was performed with successful outcomes in 5 patients with degenerated mitral valve bioprostheses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: